SHENYANG, China, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2010 after the Nasdaq Stock Exchange closes on Tuesday, March 15, 2011 at 8:00pm (Eastern).
Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) on Wednesday, March 16, 2011 to discuss its 2010 fourth quarter and fiscal year financial results and recent business activity. The conference call may be accessed using the dial-in numbers below:
Conference ID: 46216099 Local dial-in: China landline 800-819-0121 China mobile 400-620-8038 Hong Kong 852-2475-0994 International toll-free dial-in: Hong Kong 800930346 United Kingdom 080-8234-6646 United States 1-866-519-4004 International toll dial-in: 65 6723 9381 Replay- Conference ID: 46216099 A telephone replay will be available two hours after the call until March 23, 2011 at: International dial-in: 61-2-8235-5000 United States dial-in: 1-866-214-5335 Webcast
A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3SBio2010Q4.
A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 500 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see http://www.3sbio.com/ for more information.
Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: + 86 24 2581-1820 ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: + 852 8191-6991 ir@3SBio.com
3SBio Inc.
CONTACT: Investors, Bo Tan, Chief Financial Officer, 3SBio Inc., Tel: +
86 24 2581-1820, ir@3SBio.com, or Tom Folinsbee, Director of Investor
Relations 3SBio Inc., Tel: + 852 8191-6991, ir@3SBio.com
Web Site: http://www.3sbio.com/
